Peter Heerma, Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX), sold 1,126 shares at $30.75 ($34K) on 2021-02-02, disclosed to the SEC on 2021-02-03.
Scheduled sale ($34k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.75 | 563 | $17K | 51.5% |
| 2 | $28.91 | 563 | $16K | 48.5% |
| Total | $29.83 avg | 1,126 | $34K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |